{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:06:54Z","timestamp":1790309214735,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T00:00:00Z","timestamp":1693008000000},"content-version":"am","delay-in-days":329,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-CA257837"],"award-info":[{"award-number":["R01-CA257837"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jconrel.2022.08.032","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T20:03:31Z","timestamp":1661544211000},"page":"350-359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Production of paclitaxel-loaded PEG-b-PLA micelles using PEG for drug loading and freeze-drying"],"prefix":"10.1016","volume":"350","author":[{"given":"Morteza","family":"Rasoulianboroujeni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Repp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen S.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jconrel.2022.08.032_bb0005","first-page":"13","article-title":"Nanomedicines for cancer therapy: an update of fda approved and those under various stages of development","volume":"1","author":"Pillai","year":"2014","journal-title":"SOJ Pharm. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.jconrel.2022.08.032_bb0010","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1208\/s12248-012-9339-4","article-title":"Challenges in development of nanoparticle-based therapeutics","volume":"14","author":"Desai","year":"2012","journal-title":"AAPS J."},{"issue":"1","key":"10.1016\/j.jconrel.2022.08.032_bb0015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/apmc.1984.051230121","article-title":"Watersoluble polymers in medicine","volume":"123","author":"Bader","year":"1984","journal-title":"Die Angewandte Makromolekulare Chemie: Applied Macromolecular Chemistry and Physics"},{"issue":"2","key":"10.1016\/j.jconrel.2022.08.032_bb0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0939-6411(99)00039-9","article-title":"Polymeric micelles\u2013a new generation of colloidal drug carriers","volume":"48","author":"Jones","year":"1999","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"8","key":"10.1016\/j.jconrel.2022.08.032_bb0025","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.biomaterials.2009.11.077","article-title":"Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA\u2013PCL\u2013PDMAEMA triblock copolymers","volume":"31","author":"Zhu","year":"2010","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.jconrel.2022.08.032_bb0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1517\/17425240903436479","article-title":"Polymeric micelles as a new drug carrier system and their required considerations for clinical trials","volume":"7","author":"Yokoyama","year":"2010","journal-title":"Expert Opinion Drug Delivery"},{"issue":"1","key":"10.1016\/j.jconrel.2022.08.032_bb0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jconrel.2007.07.008","article-title":"What are determining factors for stable drug incorporation into polymeric micelle carriers? Consideration on physical and chemical characters of the micelle inner core","volume":"123","author":"Yamamoto","year":"2007","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.jconrel.2022.08.032_bb0040","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0169-409X(02)00047-9","article-title":"Pluronic\u00ae block copolymers for overcoming drug resistance in cancer","volume":"54","author":"Kabanov","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2022.08.032_bb0045","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0168-3659(03)00211-6","article-title":"An essential relationship between ATP depletion and chemosensitizing activity of Pluronic\u00ae block copolymers","volume":"91","author":"Kabanov","year":"2003","journal-title":"J. Control. Release"},{"issue":"38","key":"10.1016\/j.jconrel.2022.08.032_bb0050","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.1002\/ange.200250653","article-title":"Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change","volume":"115","author":"Bae","year":"2003","journal-title":"Angew. Chem."},{"issue":"2","key":"10.1016\/j.jconrel.2022.08.032_bb0055","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10549-007-9591-y","article-title":"Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer","volume":"108","author":"Lee","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"issue":"11","key":"10.1016\/j.jconrel.2022.08.032_bb0060","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1158\/1078-0432.CCR-03-0655","article-title":"Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies","volume":"10","author":"Kim","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2022.08.032_bb0065","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jconrel.2016.03.035","article-title":"Targeted delivery of low-dose dexamethasone using PCL\u2013PEG micelles for effective treatment of rheumatoid arthritis","volume":"230","author":"Wang","year":"2016","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.jconrel.2022.08.032_bb0070","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1021\/acsami.8b13059","article-title":"PEG-detachable polymeric micelles self-assembled from amphiphilic copolymers for tumor-acidity-triggered drug delivery and controlled release","volume":"11","author":"Xu","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"3","key":"10.1016\/j.jconrel.2022.08.032_bb0075","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1021\/acs.biomac.8b01430","article-title":"Rod-shaped micelles based on PHF-g-(PCL-PEG) with pH-triggered doxorubicin release and enhanced cellular uptake","volume":"20","author":"Wu","year":"2019","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2022.08.032_bb0080","series-title":"Intact or in Pieces? A Look at How Clinically Approved, Biodegradable Block Co-Polymers Affect Blood Components","author":"Maghak","year":"2020"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2022.08.032_bb0085","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0168-3659(01)00477-1","article-title":"Micelles self-assembled from poly (ethylene oxide)-block-poly (N-hexyl stearate L-aspartamide) by a solvent evaporation method: effect on the solubilization and haemolytic activity of amphotericin B","volume":"77","author":"Lavasanifar","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.032_bb0090","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jconrel.2014.12.027","article-title":"Esterase-activatable \u03b2-lapachone prodrug micelles for NQO1-targeted lung cancer therapy","volume":"200","author":"Ma","year":"2015","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.jconrel.2022.08.032_bb0095","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.nano.2011.11.005","article-title":"Paclitaxel-loaded polymeric micelles based on poly (\u025b-caprolactone)-poly (ethylene glycol)-poly (\u025b-caprolactone) triblock copolymers: in vitro and in vivo evaluation","volume":"8","author":"Zhang","year":"2012","journal-title":"Nanomedicine"},{"issue":"18","key":"10.1016\/j.jconrel.2022.08.032_bb0100","doi-asserted-by":"crossref","first-page":"9229","DOI":"10.1021\/la701157j","article-title":"Micellization and gelation of mixed copolymers P123 and F127 in aqueous solution","volume":"23","author":"Chaibundit","year":"2007","journal-title":"Langmuir"},{"issue":"7","key":"10.1016\/j.jconrel.2022.08.032_bb0105","doi-asserted-by":"crossref","first-page":"7406","DOI":"10.1021\/acsnano.8b04205","article-title":"Stereocomplex prodrugs of oligo (lactic acid) n-gemcitabine in poly (ethylene glycol)-block-poly (D, L-lactic acid) micelles for improved physical stability and enhanced antitumor efficacy","volume":"12","author":"Tam","year":"2018","journal-title":"ACS Nano"},{"issue":"28","key":"10.1016\/j.jconrel.2022.08.032_bb0110","doi-asserted-by":"crossref","first-page":"8674","DOI":"10.1021\/jacs.6b03995","article-title":"Oligo (lactic acid) n-paclitaxel prodrugs for poly (ethylene glycol)-block-poly (lactic acid) micelles: loading, release, and backbiting conversion for anticancer activity","volume":"138","author":"Tam","year":"2016","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.jconrel.2022.08.032_bb0115","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1023\/B:PHAM.0000029284.40637.69","article-title":"A novel one-step drug-loading procedure for water-soluble amphiphilic nanocarriers","volume":"21","author":"Fournier","year":"2004","journal-title":"Pharm. Res."},{"issue":"1\u20133","key":"10.1016\/j.jconrel.2022.08.032_bb0120","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jconrel.2005.09.034","article-title":"Block copolymer micelles: preparation, characterization and application in drug delivery","volume":"109","author":"Gaucher","year":"2005","journal-title":"J. Control. Release"},{"issue":"1\u20133","key":"10.1016\/j.jconrel.2022.08.032_bb0125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0168-3659(01)00492-8","article-title":"Process design for efficient and controlled drug incorporation into polymeric micelle carrier systems","volume":"78","author":"Kohori","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.032_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cplett.2020.137711","article-title":"How is a micelle formed from amphiphilic polymers in a dialysis process: insight from mesoscopic studies","volume":"754","author":"Feng","year":"2020","journal-title":"Chem. Phys. Lett."},{"issue":"43","key":"10.1016\/j.jconrel.2022.08.032_bb0135","doi-asserted-by":"crossref","first-page":"39603","DOI":"10.1021\/acsami.9b13851","article-title":"Overcoming the anatomical and physiological barriers in topical eye surface medication using a peptide-decorated polymeric micelle","volume":"11","author":"Lin","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2022.08.032_bb0140","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijpharm.2008.12.033","article-title":"Morphology and in vitro release kinetics of drug-loaded micelles based on well-defined PMPC\u2013b\u2013PBMA copolymer","volume":"371","author":"Chu","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.jconrel.2022.08.032_bb0145","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jconrel.2005.02.010","article-title":"Enhancement of oral bioavailability of poorly water-soluble drugs by poly (ethylene glycol)-block-poly (alkyl acrylate-co-methacrylic acid) self-assemblies","volume":"104","author":"Sant","year":"2005","journal-title":"J. Control. Release"},{"issue":"1\u20133","key":"10.1016\/j.jconrel.2022.08.032_bb0150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0168-3659(99)00133-9","article-title":"Doxorubicin-loaded poly (ethylene glycol)\u2013poly (\u03b2-benzyl-l-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance","volume":"64","author":"Kataoka","year":"2000","journal-title":"J. Control. Release"},{"issue":"2\u20133","key":"10.1016\/j.jconrel.2022.08.032_bb0155","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0168-3659(97)00039-4","article-title":"Block copolymer micelles for drug delivery: loading and release of doxorubicin","volume":"48","author":"Kwon","year":"1997","journal-title":"J. Control. Release"},{"issue":"7","key":"10.1016\/j.jconrel.2022.08.032_bb0160","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1023\/B:PHAM.0000033005.25698.9c","article-title":"Preparation and drug loading of poly (ethylene glycol)-block-poly (\u03b5-caprolactone) micelles through the evaporation of a cosolvent azeotrope","volume":"21","author":"Jette","year":"2004","journal-title":"Pharm. Res."},{"issue":"6","key":"10.1016\/j.jconrel.2022.08.032_bb0165","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/polb.10739","article-title":"Preparation of block copolymer vesicles in solution","volume":"42","author":"Lim Soo","year":"2004","journal-title":"J. Polym. Sci. B Polym. Phys."},{"issue":"50","key":"10.1016\/j.jconrel.2022.08.032_bb0170","doi-asserted-by":"crossref","first-page":"15350","DOI":"10.1021\/acs.langmuir.8b02992","article-title":"From tunable DNA\/polymer self-assembly to tailorable and morphologically pure core\u2013shell nanofibers","volume":"34","author":"Wang","year":"2018","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2022.08.032_bb0175","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.colsurfb.2015.07.075","article-title":"Organic solvent-free low temperature method of preparation for self assembled amphiphilic poly (\u03f5-caprolactone)\u2013poly (ethylene glycol) block copolymer based nanocarriers for protein delivery","volume":"135","author":"Payyappilly","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"1","key":"10.1016\/j.jconrel.2022.08.032_bb0180","first-page":"3","article-title":"Organic solvents in the pharmaceutical industry","volume":"67","author":"Grodowska","year":"2010","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.032_bb0185","first-page":"1","article-title":"Impurities: Guideline for residual solvents Q3C (R5)","volume":"4","author":"Guideline","year":"2005","journal-title":"Current Step"},{"issue":"1","key":"10.1016\/j.jconrel.2022.08.032_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-019-1945-9","article-title":"Translational formulation of nanoparticle therapeutics from laboratory discovery to clinical scale","volume":"17","author":"Feng","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jconrel.2022.08.032_bb0195","series-title":"Method for the Preparation of Polymeric Micelle Via Phase Separation of Block Copolymer","author":"Seo","year":"2009"},{"issue":"3","key":"10.1016\/j.jconrel.2022.08.032_bb0200","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jconrel.2010.08.021","article-title":"Paclitaxel-loaded Pluronic nanoparticles formed by a temperature-induced phase transition for cancer therapy","volume":"148","author":"Oh","year":"2010","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.jconrel.2022.08.032_bb0205","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/17425247.2016.1182485","article-title":"Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications","volume":"13","author":"D\u2019souza","year":"2016","journal-title":"Expert Opinion Drug Delivery"},{"key":"10.1016\/j.jconrel.2022.08.032_bb0210","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.molliq.2012.10.013","article-title":"Determination of critical micelle concentration of polybutadiene-block-poly (ethyleneoxide) diblock copolymer by fluorescence spectroscopy and dynamic light scattering","volume":"177","author":"Topel","year":"2013","journal-title":"J. Mol. Liq."},{"issue":"1","key":"10.1016\/j.jconrel.2022.08.032_bb0215","doi-asserted-by":"crossref","first-page":"1600194","DOI":"10.1002\/mabi.201600194","article-title":"Triolimus: a multi-drug loaded polymeric micelle containing paclitaxel, 17-AAG, and rapamycin as a novel radiosensitizer","volume":"17","author":"Tomoda","year":"2017","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2022.08.032_bb0220","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jconrel.2019.02.017","article-title":"Poly (ethylene glycol)-block-poly (d, l-lactic acid) micelles containing oligo (lactic acid) 8-paclitaxel prodrug: In Vivo conversion and antitumor efficacy","volume":"298","author":"Tam","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.032_bb0225","first-page":"1","article-title":"Surfactant micelle characterization using dynamic light scattering","author":"Note","year":"2006","journal-title":"J. Phys. Chem. B"},{"issue":"2","key":"10.1016\/j.jconrel.2022.08.032_bb0230","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jconrel.2003.11.003","article-title":"The effects of Pluronic block copolymers on the aggregation state of nystatin","volume":"95","author":"Croy","year":"2004","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.jconrel.2022.08.032_bb0235","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/pj.2016.110","article-title":"Competition between the micellization and the liquid\u2013liquid phase separation in amphiphilic block copolymer solutions","volume":"49","author":"Sato","year":"2017","journal-title":"Polym. J."},{"issue":"4","key":"10.1016\/j.jconrel.2022.08.032_bb0240","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41557-019-0210-4","article-title":"Liquid\u2013liquid phase separation during amphiphilic self-assembly","volume":"11","author":"Ianiro","year":"2019","journal-title":"Nat. Chem."},{"key":"10.1016\/j.jconrel.2022.08.032_bb0245","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.jconrel.2020.11.008","article-title":"Acyl and oligo(lactic acid) prodrugs for PEG-b-PLA and PEG-b-PCL nano-assemblies for injection","volume":"330","author":"Repp","year":"2021","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2022.08.032_bb0250","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11095-007-9451-9","article-title":"Paclitaxel prodrugs with sustained release and high solubility in poly (ethylene glycol)-b-poly (\u03b5-caprolactone) micelle nanocarriers: pharmacokinetic disposition, tolerability, and cytotoxicity","volume":"25","author":"Forrest","year":"2008","journal-title":"Pharm. Res."},{"issue":"11","key":"10.1016\/j.jconrel.2022.08.032_bb0255","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1021\/jm800002y","article-title":"Modulating the therapeutic activity of nanoparticle delivered paclitaxel by manipulating the hydrophobicity of prodrug conjugates","volume":"51","author":"Ansell","year":"2008","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.jconrel.2022.08.032_bb0260","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/jbm.a.31504","article-title":"Amphotericin B-loaded poly (ethylene glycol)\u2013poly (lactide) micelles: preparation, freeze-drying, and in vitro release","volume":"85","author":"Yang","year":"2008","journal-title":"J. Biomed. Mater. Res. A"},{"issue":"15","key":"10.1016\/j.jconrel.2022.08.032_bb0265","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.addr.2006.09.017","article-title":"Freeze-drying of nanoparticles: formulation, process and storage considerations","volume":"58","author":"Abdelwahed","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"45","key":"10.1016\/j.jconrel.2022.08.032_bb0270","doi-asserted-by":"crossref","first-page":"10260","DOI":"10.1039\/D0SM01601B","article-title":"X-ray scattering study on the crystalline and semi-crystalline structure of water\/PEG mixtures in their eutectic phase diagram","volume":"16","author":"Kuttich","year":"2020","journal-title":"Soft Matter"},{"issue":"2","key":"10.1016\/j.jconrel.2022.08.032_bb0275","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejpb.2011.03.010","article-title":"The freezing step in lyophilization: physico-chemical fundamentals, freezing methods and consequences on process performance and quality attributes of biopharmaceuticals","volume":"78","author":"Kasper","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"21","key":"10.1016\/j.jconrel.2022.08.032_bb0280","doi-asserted-by":"crossref","first-page":"10935","DOI":"10.1021\/acs.analchem.5b03003","article-title":"Thermal degradation of small molecules: a global metabolomic investigation","volume":"87","author":"Fang","year":"2015","journal-title":"Anal. Chem."},{"issue":"12","key":"10.1016\/j.jconrel.2022.08.032_bb0285","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1093\/annonc\/mdm374","article-title":"Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer","volume":"18","author":"Kim","year":"2007","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.jconrel.2022.08.032_bb0290","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ijrobp.2013.02.009","article-title":"Preclinical evaluation of Genexol-PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non-small cell lung cancer","volume":"86","author":"Werner","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.jconrel.2022.08.032_bb0295","series-title":"Nanoparticle Formulations, Google Patents No. 2014, WO2014165829A2","author":"Trieu","year":"2014"},{"key":"10.1016\/j.jconrel.2022.08.032_bb0300","first-page":"467","article-title":"Targeted therapy using nanotechnology: focus on cancer","volume":"9","author":"Sanna","year":"2014","journal-title":"Int. J. Nanomedicine"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922005375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922005375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:31:00Z","timestamp":1759163460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922005375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":60,"alternative-id":["S0168365922005375"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.08.032","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Production of paclitaxel-loaded PEG-b-PLA micelles using PEG for drug loading and freeze-drying","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.08.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}